Christina Willwerth Flexion Therapeutics Inc (FLXN) insider trading activity
Christina Willwerth is Chief Strategy Officer of Flexion Therapeutics Inc. Currently has a direct ownership of 0 shares of FLXN, which is worth approximately $0. The most recent transaction as insider was on Nov 19, 2021, when has been sold 141,241 shares (Common Stock) at a price of $8.5 per share, resulting in proceeds of $1,200,548. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
0
0%
3M change
0%
12M change
Total Value Held
$0
Christina Willwerth Transaction History
CW
Christina Willwerth
Chief Strategy Officer
Burlington, MA